Login / Signup

WhichP450: a multi-class categorical model to predict the major metabolising CYP450 isoform for a compound.

Peter A HuntMatthew D SegallJonathan D Tyzack
Published in: Journal of computer-aided molecular design (2018)
In the development of novel pharmaceuticals, the knowledge of how many, and which, Cytochrome P450 isoforms are involved in the phase I metabolism of a compound is important. Potential problems can arise if a compound is metabolised predominantly by a single isoform in terms of drug-drug interactions or genetic polymorphisms that would lead to variations in exposure in the general population. Combined with models of regioselectivities of metabolism by each isoform, such a model would also aid in the prediction of the metabolites likely to be formed by P450-mediated metabolism. We describe the generation of a multi-class random forest model to predict which, out of a list of the seven leading Cytochrome P450 isoforms, would be the major metabolising isoforms for a novel compound. The model has a 76% success rate with a top-1 criterion and an 88% success rate for a top-2 criterion and shows significant enrichment over randomised models.
Keyphrases
  • clinical trial
  • healthcare
  • randomized controlled trial
  • climate change
  • open label
  • study protocol
  • double blind
  • drug induced